N
Nalinee Sangrujee
Researcher at Centers for Disease Control and Prevention
Publications - 18
Citations - 736
Nalinee Sangrujee is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Cost effectiveness & Population. The author has an hindex of 14, co-authored 18 publications receiving 707 citations.
Papers
More filters
Journal ArticleDOI
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: A combined analysis of 12 mathematical models
Jeffrey W. Eaton,Nicolas A Menzies,John Stover,Valentina Cambiano,Leonid Chindelevitch,Anne Cori,Jan A. C. Hontelez,Jan A. C. Hontelez,Jan A. C. Hontelez,Salal Humair,Cliff C. Kerr,Daniel J. Klein,Sharmistha Mishra,Sharmistha Mishra,Kate M. Mitchell,Brooke E Nichols,Peter Vickerman,Roel Bakker,Till Bärnighausen,Till Bärnighausen,Anna Bershteyn,David E. Bloom,Marie-Claude Boily,Stewart T. Chang,Ted Cohen,Ted Cohen,Peter J. Dodd,Christophe Fraser,Chaitra Gopalappa,Jens D Lundgren,Jens D Lundgren,Natasha K. Martin,Natasha K. Martin,Evelinn Mikkelsen,Elisa Mountain,Quang D. Pham,Michael Pickles,Andrew N. Phillips,Lucy Platt,Carel Pretorius,H Prudden,Joshua A. Salomon,David A. M. C. van de Vijver,Sake J. de Vlas,Bradley G. Wagner,Richard G. White,David Wilson,Lei Zhang,John M. Blandford,Gesine Meyer-Rath,Gesine Meyer-Rath,Michelle Remme,Paul Revill,Nalinee Sangrujee,Fern Terris-Prestholt,Meg Doherty,Nathan Shaffer,Philippa Easterbrook,Gottfried Hirnschall,Timothy B. Hallett +59 more
TL;DR: Estimates suggest that earlier eligibility for antiretroviral therapy is very cost effective in low-income and middle-income settings, although these estimates should be revisited when more data become available.
Journal ArticleDOI
Cost-Effectiveness Analysis of Diagnostic Options for Pneumocystis Pneumonia (PCP)
TL;DR: For diagnosis of PCP, use of PCR technologies, when combined with less-invasive patient specimens such as expectorated or induced sputum, represent more cost-effective options than any diagnostic procedure using BAL, or chest x-ray alone.
Journal ArticleDOI
Cost-effectiveness of three different vaccination strategies against measles in Zambian children
Gustavo H. Dayan,Lisa Cairns,Nalinee Sangrujee,Anne Mtonga,Van Cuong Nguyen,Peter M. Strebel +5 more
TL;DR: A vaccination program which includes SIAs reaching children not previously vaccinated would prevent on additional 29,242 measles cases and 1462 deaths for each vaccinated birth cohort when compared with a one-dose program.
Journal ArticleDOI
HIV Treatment as Prevention: Issues in Economic Evaluation
TL;DR: Economic evaluations of antiretroviral therapy in currently existing programs and in HIV treatment as prevention (TasP) programs should use cost functions that capture cost dependence on a number of factors, such as scale and scope of delivery.
Journal ArticleDOI
Cost analysis of post-polio certification immunization policies
TL;DR: Projections on the vaccine price per dose and future coverage rates were major drivers of the global costs of post-certification polio immunization.